RxDoctor Payments Data

Maria Arcila, MD

Anatomic Pathology & Clinical Pathology · New York, NYNPI 1760550594

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,027 of the $41,815 with a category attached, or 79.0%. 8 manufacturers reported payments, led by Astrazeneca UK Limited at 32.3% of the total. Among anatomic pathology & clinical pathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,815in general payments, 2019–2025

Across 23 payments — averaging $1818.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$13K
  • AstraZeneca$9K
  • Biocartis US, Inc$8K
  • Merck$3K
  • Roche Diagnostics Corporation$3K
  • Sanofi$2K
  • plus $2K from 2 others

What the payments were for

  • Consulting fees$33,02779%
  • Speaking & faculty fees$3,5008%
  • Travel & lodging$3,1257%
  • Food & beverage$2,1635%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited4$13,486
AstraZeneca6$9,424
Biocartis US, Inc7$8,394
Merck1$3,270
Roche Diagnostics Corporation1$2,900
Sanofi2$2,405
E.r. Squibb & Sons, L.L.C.1$1,125
Janssen Research & Development, LLC1$810

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,815 in reported general payments places this provider in the 95th percentile of 468 anatomic pathology & clinical pathology providers in New York.

See all anatomic pathology & clinical pathology providers in New York

Medicare billing

Part B allowed, 2024
$28,161
Medicare patients
477
Services billed
570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →